Original Article
Metabolic Liver Diseases
|
USP10 Alleviates Palmitic Acid-induced Steatosis through Autophagy in HepG2 Cells
Sheng-Liang Xin, Xiao-Li Pan, Xiao-Yuan Xu, Yan-Yan Yu
Published online: March 31, 2022
doi:10.14218/JCTH.2022.00060
|
|
Prognostic Relevance of Metabolic Dysfunction-associated Steatohepatitis for Patients with Chronic Hepatitis B
Manus Rugivarodom, Ananya Pongpaibul, Siwaporn Chainuvati, Supot Nimanong, Watcharasak Chotiyaputta, Tawesak Tanwandee, Phunchai Charatcharoenwitthaya
Published online: May 23, 2022
doi:10.14218/JCTH.2022.00055
|
Infectious Hepatitis
|
Adverse Effect of Nonalcoholic Fatty Liver Disease on the Therapeutic Response in Patients with Chronic Hepatitis B
Siyu Zhang, Xiaoxiao Zhang, Huiming Jin, Yao Dou, Lu Li, Xiwei Yuan, Chen Dong, Mengmeng Hou, Yue-min Nan, Jia Shang
Published online: May 13, 2022
doi:10.14218/JCTH.2022.00066
|
|
Efficacy and Safety of Sofosbuvir-based Regimens in Hepatitis C Patients With Decompensated Cirrhosis: A Systematic Review and Meta-analysis
Wenyan Zhang, Jing Zhang, Shan Tang, Yali Liu, Xiaofei Du, Lixia Qiu, Menglu Liu, Haibin Yu, Calvin Q. Pan
Published online: June 28, 2022
doi:10.14218/JCTH.2022.00006
|
DILI, Autoimmune, and Cholestatic Diseases
|
Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry
Sakkarin Chirapongsathorn, Wattana Sukeepaisarnjaroen, Sombat Treeprasertsuk, Roonguedee Chaiteerakij, Pichaporn Surawongsin, Chanunta Hongthanakorn, Sith Siramolpiwat, Naichaya Chamroonkul, Chalermrat Bunchorntavakul, Watcharasak Chotiyaputta, Kittiyod Poovorawan, Rattana Boonsirichan, Saranath Lawpoolsri, Chinnavat Sutivana, Abhasnee Sobhonslidsuk
Published online: June 15, 2022
doi:10.14218/JCTH.2021.00479
|
|
MALAT1-mediated EZH2 Recruitment to the GFER Promoter Region Curbs Normal Hepatocyte Proliferation in Acute Liver Injury
Li Chen, Xintong Kang, Xiujuan Meng, Liang Huang, Yiting Du, Yilan Zeng, Chunfeng Liao
Published online: April 15, 2022
doi:10.14218/JCTH.2021.00391
|
|
Clinical and Genetic Characteristics of Alagille Syndrome in Adults
Jianguo Li, Haicong Wu, Shuru Chen, Jiahui Pang, Heping Wang, Xinhua Li, Weiqiang Gan
Published online: March 17, 2022
doi:10.14218/JCTH.2021.00313
|
|
Neonatal Dubin-Johnson Syndrome and its Differentiation from Biliary Atresia
Teng Liu, Jing Zhao, Jia-Yan Feng, Yi Lu, Jonathan A. Sheps, Ren-Xue Wang, Jun Han, Victor Ling, Jian-She Wang
Published online: March 11, 2022
doi:10.14218/JCTH.2021.00460
|
Liver Failure, Cirrhosis and Portal Hypertension
|
Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis via the TGF-β1/SMAD3 Pathway In Vivo and In vitro
Shiwei Wang, Lingling He, Fan Xiao, Meixin Gao, Herui Wei, Junru Yang, Yang Shu, Fuyang Zhang, Xiaohui Ye, Ping Li, Xiaohua Hao, Xingang Zhou, Hongshan Wei
Published online: May 26, 2022
doi:10.14218/JCTH.2022.00005
|
|
Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection
Cyriac Abby Philips, Rizwan Ahamed, Jinsha K.P. Abduljaleel, Sasidharan Rajesh, Philip Augustine
Published online: June 13, 2022
doi:10.14218/JCTH.2021.00428
|
|
Naringenin is a Potential Immunomodulator for Inhibiting Liver Fibrosis by Inhibiting the cGAS-STING Pathway
Li Chen, Siwei Xia, Shuqi Wang, Yuanyuan Zhou, Feixia Wang, Zhanghao Li, Yang Li, Desong Kong, Zili Zhang, Jiangjuan Shao, Xuefen Xu, Feng Zhang, Shizhong Zheng
Published online: April 28, 2022
doi:10.14218/JCTH.2022.00120
|
|
MELD or MELD-Na as a Predictive Model for Mortality Following Transjugular Intrahepatic Portosystemic Shunt Placement
Arunkumar Krishnan, Tinsay A. Woreta, Dhananjay Vaidya, Yisi Liu, James P. Hamilton, Kelvin Hong, Alia Dadabhai, Michelle Ma
Published online: July 13, 2022
doi:10.14218/JCTH.2021.00513
|
|
Dissecting the Contributing Role of Divergent Adipose Tissue to Multidimensional Frailty in Cirrhosis
Lihong Mao, Chaoqun Li, Xiaoyu Wang, Mingyu Sun, Yifan Li, Zihan Yu, Binxin Cui, Gaoyue Guo, Wanting Yang, Yangyang Hui, Xiaofei Fan, Jie Zhang, Kui Jiang, Chao Sun
Published online: April 20, 2022
doi:10.14218/JCTH.2022.00027
|
|
Efficacy and Safety of Yanggan Jian in Hepatitis B Virus-related Decompensated Cirrhosis: A Randomized, Double-blind, Controlled Trial
Long Chen, Chaoqun Zhao, Weili Yao, Wei Liu, Hua Zhang, Yongping Mu, Hong Cai, Dongying Xue, Chengbao Wang, Wan’e Wang, Yuehong Lin, Jiamei Chen, Ping Liu
Published online: April 8, 2022
doi:10.14218/JCTH.2021.00451
|
Hepatic and Biliary Neoplasia
|
Integrin α6 Targeted Near Infrared Fluorescent Imaging and Photoacoustic Imaging of Hepatocellular Carcinoma in Mice
Yan-Zhu Lin, You Wu, De-Hai Cao, Yong-Jian Peng, Jun Deng, Wen-Jie Lin, Min-Yi Si-Tu, Ling Zhuo, Jie-Min Chen, Man-Xia Lei, Rong-Bin Liu, Wei-Guang Zhang, Jian-Jun Li, Xiao-Chun Yang, Guo-Kai Feng
Published online: April 12, 2022
doi:10.14218/JCTH.2021.00414
|
|
Hepatitis B Virus Surface Antigen Promotes Stemness of Hepatocellular Carcinoma through Regulating MicroRNA-203a
Yu-Fei Qin, Zi-Yu Zhou, Hou-Wei Fu, Hao-Ming Lin, Lei-Bo Xu, Wen-Rui Wu, Chao Liu, Xiao-Lin Xu, Rui Zhang
Published online: July 26, 2022
doi:10.14218/JCTH.2021.00373
|
Liver Transplantation and Surgery
|
Impact of COVID-19 on Liver Transplant Activity in the USA: Variation by Etiology and Cirrhosis Complications
Yong-Fang Kuo, Paul Kwo, Robert J Wong, Ashwani K. Singal
Published online: August 18, 2022
doi:10.14218/JCTH.2022.00129
|
Review Article
|
The Gut Microbiome and Ferroptosis in MAFLD
Jie Ji, Liwei Wu, Jue Wei, Jianye Wu, Chuanyong Guo
Published online: July 14, 2022
doi:10.14218/JCTH.2022.00136
|
|
Selective Androgen Receptor Modulators: An Emerging Liver Toxin
Haseeb Mohideen, Hafsa Hussain, Dushyant Singh Dahiya, Hisham Wehbe
Published online: November 4, 2022
doi:10.14218/JCTH.2022.00207
|
|
An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss
Zi-Long Wang, Jia-Rui Zheng, Rui-Feng Yang, Lin-Xiang Huang, Hong-Song Chen, Bo Feng
Published online: August 22, 2022
doi:10.14218/JCTH.2022.00289
|
|
Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma
Ziyue Huang, Haoming Xia, Yunfu Cui, Judy Wai Ping Yam, Yi Xu
Published online: August 31, 2022
doi:10.14218/JCTH.2022.00255
|
|
Assessing Donor Liver Quality and Restoring Graft Function in the Era of Extended Criteria Donors
Yimou Lin, Haitao Huang, Lifeng Chen, Ruihan Chen, Jimin Liu, Shusen Zheng, Qi Ling
Published online: August 16, 2022
doi:10.14218/JCTH.2022.00194
|
|
Multifaceted Influence of Histone Deacetylases on DNA Damage Repair: Implications for Hepatocellular Carcinoma
Gan Du, Ruizhe Yang, Jianguo Qiu, Jie Xia
Published online: September 13, 2022
doi:10.14218/JCTH.2022.00079
|
|
Ablation for Benign Liver Tumors: Current Concepts and Limitations
Hitoshi Maruyama, Maki Tobari, Hiroaki Nagamatsu, Tadashi Yamaguchi, Shuichiro Shiina
Published online: September 6, 2022
doi:10.14218/JCTH.2022.00205
|
Illuminating and Instructive Clinical Case
|
Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence
Marco Ferronato, Claudine Lalanne, Chiara Quarneti, Michele Cevolani, Chiara Ricci, Alessandro Granito, Luigi Muratori, Marco Lenzi
Published online: May 24, 2022
doi:10.14218/JCTH.2021.00573
|